Please login to the form below

Not currently logged in
Email:
Password:

generic drugs

This page shows the latest generic drugs news and features for those working in and with pharma, biotech and healthcare.

Heron boosted by new data for ‘breakthrough’ pain drug

Heron boosted by new data for ‘breakthrough’ pain drug

If approved it will challenge current drugs for post-operative pain including Pacira Pharma’s Exparel (liposomal bupivacaine), which made $283m in sales last year despite the fact that the market ... segment is largely served by low-cost generic drugs.

Latest news

More from news
Approximately 3 fully matching, plus 295 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    The main drivers of revenue for Roche are well-established, standard-of-care blockbuster oncology drugs including Rituxan, Herceptin and Avastin. ... Roche will likely take the biggest loss in Europe, where nationalised healthcare systems are keen to

  • Deal Watch June 2016 Deal Watch June 2016

    The three deals with Mayne Pharma, Impax Laboratories and Dr Reddy's, for a combined value of over $1.5bn, cover portfolios of marketed and approved generic drugs, drugs currently pending ... 8 generic drugs - filed ANDAs pending approval and an approved

  • Cost containment and the German market Cost containment and the German market

    They represent an established instrument of cost control, especially in the generic segment, as 93% of all drugs under rebate contract are generics. ... Focusing on patented drugs, the price difference to the generic segment is significant.

  • Deal Watch February 2016 Deal Watch February 2016

    Licensor Acquired/Licensee Acquirer. Product/Technology. Deal Type. Headline ($m). Meda/Mylan. portfolio of branded, OTC and generic drugs.

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    Today. Per the legislation, generic drugs will have to pay an additional rebate on top of the basic rebate. ... As a result, 340B prices for generic drugs may be lowered as Medicaid URAs become higher.

More from intelligence
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Elite Pharma names Actavis VP as CEO Elite Pharma names Actavis VP as CEO

    These include 12 generic drugs already approved by the US Food and Drug Administration (FDA) but are yet to be marketed. ... An additional generic product is under review. “ Nasrat has broad experience in both branded and generic pharmaceuticals as

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics